FONAR (FONR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Mar, 2026Executive summary
A special committee of independent directors negotiated a merger agreement for a going-private transaction, resulting in a cash buyout of all outstanding shares not owned by the acquisition group, at $19.00 per share for Common and Class B, $6.34 for Class C, and $10.50 for Class A Non-voting Preferred Stock, representing significant premiums to recent trading prices.
The merger will result in the company becoming a wholly owned subsidiary of a parent entity controlled by the CEO and other insiders, with all public shares converted to cash and the company delisted from Nasdaq.
The transaction is subject to approval by both a majority of all voting shares and a majority of votes cast by disinterested stockholders, as well as a potential supermajority requirement under Delaware law due to ongoing litigation.
The special committee, with independent legal and financial advisors, unanimously determined the merger is fair to unaffiliated stockholders, supported by a fairness opinion from Marshall & Stevens.
The board recommends voting in favor of the merger and adjournment proposals at the special meeting.
Voting matters and shareholder proposals
Stockholders are asked to vote on the merger proposal and an adjournment proposal to allow additional proxy solicitation if needed.
Approval requires both a majority of all voting shares and a majority of votes cast by disinterested stockholders, with a possible 66 2/3% supermajority requirement pending litigation.
Voting agreements have been executed by insiders and rollover stockholders to support the merger.
Appraisal rights are available for stockholders who do not vote in favor and comply with statutory requirements.
Board of directors and corporate governance
The special committee consisted of two independent, disinterested directors empowered to negotiate and recommend the transaction.
Interested directors recused themselves from deliberations and voting on the merger.
The board, following the special committee's recommendation, determined the merger is fair and in the best interests of unaffiliated stockholders.
After the merger, the CEO will serve as sole director and executive officer of the surviving corporation.
Latest events from FONAR
- Independent directors secured a cash buyout at a premium, pending key stockholder approvals.FONR
Proxy Filing26 Feb 2026 - Six-month net income fell 16%, but quarterly net income rose 15%; merger at $19/share signed.FONR
Q2 202617 Feb 2026 - Definitive merger agreement signed for $19.00/share; quarterly net income up 15% year-over-year.FONR
Proxy Filing17 Feb 2026 - Management-led buyout at $19/share offers 31.5% premium, pending shareholder approval.FONR
Proxy Filing30 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditors amid continued growth and strong liquidity.FONR
Proxy Filing2 Dec 2025 - Revenue up 4% to $26M, but net income down 33% as costs rise and uncertainty persists.FONR
Q1 202614 Nov 2025 - Revenue up 1%, net income down 24%, with record scan volumes and expansion plans.FONR
Q4 202525 Sep 2025 - Net income rose 16% on record scan volumes and continued expansion of MRI centers.FONR
Q4 202413 Jun 2025 - MRI scan volume rose, but revenue and net income declined amid higher costs and disruptions.FONR
Q1 202513 Jun 2025